Connect with us

Cannabis News

Trucking Industry Group Is ‘Deeply Concerned’ About Marijuana Rescheduling’s Potential Impact On Drug Testing For Drivers

Published

9 months ago

on

American truck associations (ATA) say that “very worried” is in drug testing programs.

Sean Duffy Sean Duffy, Dan Horvath, said Dan Horvath. Dan Horvath is capable of achieving the authority and ability to control the transport employees of the marijuana commercial engine (CMV) and security staff “.

Of course, this policy has not yet been prescribed. And while President Donald Trump said he will take a decision about the recently mentioned proposal in the week-Txo protect the reform on the route of the campaign last year – should be seen whether he wants to continue the restoration.

Horvath said that the door “does not have a formal position to legalize or deregulation,” we are very worried about re-programming safety risks, testing the authority and technical requirements for the necessary security staff. “

Concern is a potential guideline for the compulsory federal drug test if they will now be transferred to the Cannabis III Program.

“If so, dot programs to keep programs without cleaning, to maintain marijuana testing authority, and such federal policy changes can be serious consequences for highway safety and national transport network,” letters said. “This risk is not a proven standard, a highly accepted standard before the roadside or before the driver starts working before the vehicle is harder to prevent driving disability.”

“The implications of a gap in the test authority are well documented in the implications of potential security,” Horvath said, pointing to the data The rate of Positive Thc among the driver And research showed the increase in traffic death after state legalization.

“The door has repeatedly transmitted these concerns, and our demand about potential clarity, in the DOT test program, according to the previous administration, both in discussions about formal letters and people”. new According to transport issues.

Horvath also noticed Pete Buttigieg while the Secretary of Transportation has told a conference committee last year Rescheduling would not affect drug testing regulationsAta “never received Answer to our correspondence Explain the basis of this position or explain the details that intend to deal with impacts in the program. “

“The public attention of marijuana policy and marijuana is a federal novelty, we want to effectively coordinate the change in the HHS (Department of Justice) to ensure the authority, tools and technical skills in controlling federal policy.”

Meanwhile, a policy in a couple of companies in the truck industry premiered in April, which sought was approximately 80,000 drivers Positive to marijuana says staff had aggravated Zero-tolerance drug policy below dot.

MARIHUANA Moving III “dot regulations and drug test protocols”, papers, for example, recognizing legal medical use and reducing social stigma, but should not be facilitated.

Dot drug screening program usually uses urinary-based tests, but the report says that Saliva and hair follicle test provides benefits in this standard. It is warned that “there is no extended test today to determine whether a driver is exposed to a drug like THC.”

The Department ended the new test policy in 2023 Allow oral salt drug testing as an alternative to testing based on urine. Late Last last year, critics fell more than half years after the end of the authority, Fixed officials had yet to use the necessary infrastructure to use the new test procedure.

Legislators of Congress Auditions in March The truck industry representatives heard that they called the use of hair follicle tests in the industry. President of the National Transport Safety Commission (NTSB) recommended better education for drivers.

In April, the US Supreme Court A Cannabis company sued for a truck after shooting for a positive THC test He said consuming the CBD product derived from hemp.

Separately, substance abuse and mental health services administration (Samhsa) Official Criticism of a drug testing drug testing “means a drug test” means Canavies use cannabis to do with the nearby impunityA couple of days while avoiding drug test. “

The Transport Industry also recommended the Congress in January If Marijuana is federally restructuring, businesses do not ensure that zero tolerance policies do not need drivers-The key problem of the questionnaire is lacking technology to detect driving handicap.

Report of the 2023 Congress of Congress of Transport, Housing and Urban Development and Related Agencies (Thud), the House Credit Committee “Marijuana impairment measurement measurement is continued to measure the measurement test measurement of sobriety tests to ensure highway security. “

A year earlier in Colorado John Hickenlooper (D) Senin sent the letter to the point Looking for an update in this state of a federal report In the roads that inhibit the development of standardized marijuana deterioration on the roads. The Department Report had to complete Under a large-scale infrastructure bill Then signed by President Joe Biden, but The deadline he reported.

Meanwhile, the National Transport Safety Commission (NTSB) warned Marijuana again program “blind places” to test federally regulated employee tests in security sensitive positions.

On the home committee, then the Dot Secretary mentioned concerns about the door “about the general public” Effects of Highway National System Appeal and Safety Conclusions And his users, “Truck Associations were thrown in a letter to the secretary.

The current federal laws promise to abstain by commercial drivers from cannabis to different types of drug performances, pre-work, random tests.

In June 2022, they found the ATRI survey of the US Licensed Truck Drivers 72.4 percent “release” supports cannabis law and test policies. Another 66.5, 66.5 said Marijuana had to be legalized federally.

Cannabis deforms reforms, while, too The federal civil servant called the “discriminatory” drug test practice around the truck industry.

Fargo Analysis A top well said in 2022 that the main reason for raising costs and staff in the transport sector: marijuana criminalization and As a result, drug testing orders This follows as more states legalize.

Later representative. Earl Blumenoer (or) sent a letter to Motura in 2022, emphasizing that they are policies about the drug testing truck and commercial marijuana useless people cost their work And it helps supply chain problems.

2022 ATRI reports that the impact of cannabis is affected and the impact on motorway security is currently confused, complicating the judgment to correct the problem. A separate 2019 Congress Research Service Report (CRS) It has also been found that evidence of the decline in cannabis is not inclusive.

Read ata’s print Maryhuana rewrite and drug testing followed:

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

Missouri cannabis growers file class action against Good Day Farm

Published

6 hours ago

on

April 30, 2026

By

CPC of Missouri-Smithville, LLC and GF Saint Mary LLC, licensed cannabis growers and manufacturers in Missouri, filed a lawsuit in the Circuit Court of Jackson County on behalf of independent wholesalers, alleging that Good Day Farm (GDF) and its network of conspiring companies and investors were harmed by an intentional, coordinated and unconstitutional scheme. The complaint alleges that the “GDF Cartel” illegally controls or manages the state’s share of dispensary licenses and uses that market power to manipulate Missouri’s $1.52 billion cannabis market for its own profit.

GDF and its co-conspirators allegedly built the cartel by arranging for third parties to invest in limited liability companies (LLCs) that then acquire additional dispensaries, cultivation and processing facilities, all of which are owned, operated or controlled by GDF. The result: The alleged cartel exercises effective control over at least 61 dispensaries, nearly triple the 22 allowed by the Missouri Constitution, with more than 10% of dispensary licenses “under substantially common control, ownership or management.” With 224 dispensaries currently licensed statewide, the alleged GDF Cartel controls more than one in four dispensary licenses in Missouri. But its influence is even greater, with alleged Cartel dispensaries accounting for more than 40% of wholesale cannabis in the state, giving it significant — and illegal — influence over all independent growers and manufacturers forced to sell through its network.

To avoid the Missouri Constitution’s 10% licensing limit and avoid regulatory oversight, the alleged cartel operates under five different brand names:

  • Good Day Farm (21 dispensaries),
  • CODES (20 dispensaries),
  • Green light (10 dispensaries),
  • Fresh Karma (6 dispensaries), and
  • 3 Fifteen Primo (4 medications).

But they’re all part of a single, coordinated operation, the complaint says.

  • Purchase cannabis products from non-Cartel wholesalers at artificially depressed prices;
  • They supply their 61 dispensaries with the same products—mainly those produced by Cartel growers—significantly excluding products from independent wholesalers;
  • Force independent drug wholesalers to purchase the Cartel’s finished products as a condition for their wholesale products to be placed on the Cartel’s drug store shelves; and
  • Boycott non-cartel wholesalers who refuse to agree to anti-cartel demands.

Bob Hoffman, one of the attorneys leading the case, said: “The GDF Cartel is removing competition from the wholesale cannabis market and enriching itself with illegal profits through a counterproductive, clandestine business conspiracy. Missouri growers and manufacturers have been suffering under this scheme for a long time; many of them know something is wrong, but we don’t realize how the cartel has manipulated the market through this manipulation framework. Missourians to approve recreational cannabis in 2022 They voted for a fair and competitive market. Missouri licensed cannabis businesses that have suffered these practices should join us because they may be entitled to substantial damages.”

The complaint alleges the financial toll the Cartel has taken: Since the Cartel began illegal price-fixing, it has used its collective market power to lower wholesale prices by more than 20%, and continues to squeeze wholesalers and threaten the viability of their operations.

The unconstitutional complaint alleges that GDF knew its plan to build cartels could create legal risks for the company under the Constitution’s 10% licensing limit. The complaint quotes from a document provided by GDF to potential investors: “There can be no assurance that the Missouri Department of Cannabis Regulation will not dispute the number of marijuana dispensaries operated or supervised by the operator or its affiliates…”.

This action is brought on behalf of a putative class that includes all licensed independent wholesalers in Missouri that are not members of the alleged GDF Cartel for purposes of injunctive relief. Wholesalers who believe they have been financially harmed by the alleged Cartel’s practices should join the case because they may be entitled to substantial damages. The putative class is represented by the law firms of Feuerstein Kulick LLP and Bryan Cave Leighton Paisner LLP.

Source: Feuerstein Kulick LLP and Bryan Cave Leighton Paisner LLP

Continue Reading

Cannabis News

State-Licensed Marijuana Businesses Can Now Apply For Federal Protections Using New DEA Form

Published

6 hours ago

on

April 30, 2026

By

State licensee Medical marijuana companies can apply for federal protections In line with the Trump administration’s cannabis reprogramming process.

The Drug Enforcement Administration’s “Medical Marijuana Dispensary Registry Portal” went live Wednesday morning.

The move comes after the Justice Department announced that last week Marijuana Schedule I through III of the Controlled Substances Act (CSA), in stages.

Pursuant to an order signed by Attorney General Blanche, marijuana products regulated by a state medical cannabis license were immediately moved to Title III.

III. State-licensed medical cannabis dispensaries that wish to take advantage of the new legal protections and tax benefits that come with annexation status must first file an application with the DEA requesting information about their processes for storage, ordering, distribution, inventory, record keeping and other aspects of their business.

For each activity below, indicate whether the company has a standard operating procedure (SOP):

    • the order
    • receiving
    • Inventories
    • Marijuana storage
    • security
    • Distribution (including delivery services)
    • to divide
    • Destruction/Disposal
    • Reporting Theft/Loss
    • Due diligence (including provider/patient/professional verification)
    • Corresponding Liability
    • Record keeping”

The application asks about specific details of security measures such as vaults, safes, secure storage, access controls, alarm systems and on-site security personnel.

Applicants can choose whether to apply for administration of marijuana, marijuana extracts, or naturally derived delta-9 THC.

Currently, with only medical marijuana moving to Schedule III, the application asks potential registrants whether their businesses handle or provide recreational marijuana.

According to last week’s DOJ order, an expedited administrative hearing process will be held beginning June 29 to consider the broader cannabis reorganization.

The DEA application, meanwhile, also asks companies to submit information about their state’s cannabis licenses and to answer questions about their criminal and disciplinary history.

It also asks, “Has anyone involved in the ownership or operation of the business previously manufactured, distributed, and/or provided a controlled substance without a DEA registration authorizing such activity?”

Allegedly every illegal cannabis company operating in the state today has key employees who have done so, medical marijuana was a Schedule I substance whose manufacture, distribution and general distribution was not permitted by the DEA until just a few days ago.

Applicants must also list the suppliers from whom they plan to procure marijuana, and report whether they plan to repackage or relabel cannabis products.

They must also provide lists of people whose business they expect to have “access to controlled substances,” including their dates of birth, social security numbers, and drug-related criminal histories.

“Provide the following for each person you plan to acquire controlled substances:

    • The name
    • Title(s)
    • date of birth
    • Social Security number
    • DEA registration numbers, if applicable
    • State/territory permits to manufacture, distribute, dispense, or otherwise handle controlled substances
    • Has this person been subject to one or more federal, state, territorial, or tribal disciplinary actions?
    • Has this person been convicted of federal, state, territorial, tribal, or local offenses related to controlled substances?

There is also $794 per year the application fee, currently only payable through PayPal, although DEA ​​”expects to have additional payment methods in the coming weeks.”

Application fees are non-refundable.

Separately, the DEA has launched a new web page on its website that contains key information about the new federal rescheduling move for cannabis, including copies of Federal Register orders outlining the process for the amendment and the upcoming litigation.

Blanche’s reorganization order last week said that to comply with the international drug control treaty’s “requirement that a government agency act as the exclusive purchaser of cannabis production,” the DOJ is setting in motion a process by which the federal government technically buys from marijuana producers and then sells to them or related entities.

“Registered growers must store the crops in a DEA-accessible facility until that transaction is completed, and each grower’s registration must specify the area in which the grow is allowed,” he said.

“All manufacturers registered under this subsection shall establish a nominal price for the purchase of their marijuana crops. The Administration shall then purchase the entity’s crops at that price and resell the crops to the entity, or a related or supporting entity, at the same price plus the administrative fee calculated in section 1318.06(a)..”

Meanwhile, the US Treasury and Internal Revenue Service (IRS) said they plan to issued new tax guidelines for the marijuana industry after the reorganization announcement.

The reorganization will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions that are currently prohibited under IRS Code Section III, known as Section 280E.

White House Press Secretary Karoline Leavitt said the administration is moving forward with the marijuana overhaul because Cannabis reform is “very popular” with voters and because doing so will help people who need access to the drug for medical purposes.

At the press event held in the Oval Office last week, President Donald Trump spoke about the medical benefits of marijuana.

“A lot of people are facing big problems, and that seems to be the best answer,” he said. “They’re very happy. So the reorganization begins, and that’s a big thing, the reprogramming.”

The president stated that his administration’s rescheduling of cannabis came about after his friend Howard Kessler told him about his use of medical marijuana.

“He had some medical difficulties, and it came about by chance, kind of,” he said. “He had to go through a lot of different medications, and he said this was the one that was so much better than anything else. And so he lived through that. He didn’t benefit from it, because now he lives much better from the perspective.”

“So we hope you don’t have to,” Trump said. “But if you must, I hear it’s the best of all alternatives.”

Separately, the president asked Congress to take action changing the law that threatens to federally recriminalize hemp-derived full-spectrum CBD products later this year

“We need to do this STRAIGHT and FAST, especially for those who have found CBD helping them,” he said in a social media post. “Also, I’m told it will help our BIG FARMERS that we love and will always be around.”

A few days ago, Trump denounced this Federal officials were “slowly” pursuing his cannabis warrant.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Klasmann-Deilmann announces management changes

Published

1 day ago

on

April 29, 2026

By











After fifteen years of successful cooperation, managing director Moritz Böcking and the shareholders of Klasmann-Deilmann GmbH have mutually agreed to part ways. As of May 1, 2026, Moritz Böcking will hand over the position of managing director to Jan Astrup, who served as the company’s CEO in 2021/2022. Jan Astrup and Damian Ikemann will form the Board of Directors of the Klasmann-Deilmann Group from now on.

© Klasmann-Deilmann Benelux

Klasmann-Deilmann thanks Moritz Böcking for his cooperation and the progress achieved in the transformation of the Klasmann-Deilmann Group. Moritz Böcking expanded Klasmann-Deilmann beyond the growing media business into new areas of commercial horticulture and promoted innovation and digitalization within the company. In addition, its achievements include the expansion of resources derived from renewable raw materials, as well as the acquisition of a subsidiary in Australia and production facilities in France and Canada, which operate in cooperation with external partners. He also significantly advanced Klasmann-Deilmann’s positioning as a global pioneer of sustainable development in the growing media industry, thereby making a decisive contribution to the company’s economic growth.

With Jan Astrup, Klasmann-Deilmann is getting an internationally experienced manager who has proven himself in the company and has extensive experience in raw materials, production, process optimization and technology. With the new CEO, raw materials and technology-driven areas for the substrate industry are now increasingly important at senior management level. Jan Astrup will strengthen the core commercial horticulture business and help develop the company for the future.

For more information:
Klasmann-Deilmann GmbH
(email protected)
www.klasmann-deilmann.com



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media